Jordan Park Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-21,823
Closed -$2.02M – 49
2021
Q2
$2.02M Sell
21,823
-178
-0.8% -$15.1K 0.11% 32
2021
Q1
$1.95M Buy
+22,001
New +$2.18M 0.12% 25

Other funds holding ARKG

Jordan Park Group's ARKG Position: Q3 2021 in Review

Jordan Park Group sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 21,823 shares — an estimated $2.02M sold.

Jordan Park Group first reported a position in ARKG in Q1 2021 and held it in 2 quarters. The position peaked at $2.02M in Q2 2021. 470 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • Jordan Park Group reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
  • Jordan Park Group sold 21,823 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $2.02M.
  • Jordan Park Group first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 2 quarters.
  • Jordan Park Group's ARK Genomic Revolution ETF position peaked at $2.02M in Q2 2021.
  • 470 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Jordan Park Group's 13F filing for Q3 2021, filed 19 Oct 2021.